STOCK TITAN

Owens & Minor, Inc. - OMI STOCK NEWS

Welcome to our dedicated page for Owens & Minor news (Ticker: OMI), a resource for investors and traders seeking the latest updates and insights on Owens & Minor stock.

Owens & Minor, Inc. (NYSE: OMI) is a prominent healthcare logistics company specializing in the distribution and logistics of medical products. The company plays a crucial role in ensuring the seamless delivery of vital medical supplies from manufacturers to healthcare providers. With a presence in both the United States and Europe, Owens & Minor operates strategically positioned logistics platforms that serve markets responsible for three-quarters of global healthcare spending.

Headquartered in Richmond, Virginia, this Fortune 500 company boasts annualized revenues exceeding $9 billion. Owens & Minor's diverse customer base includes independent hospitals, large integrated healthcare networks, group purchasing organizations, healthcare product manufacturers, and the federal government.

Owens & Minor operates under two main segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment focuses on the manufacturing and sourcing of medical-surgical products. This segment also provides solutions to prevent healthcare-associated infections across various healthcare settings. On the other hand, the Patient Direct segment delivers disposable medical supplies directly to patients and home health agencies, enhancing the accessibility of essential healthcare products.

Recent achievements include strategic partnerships to expand their reach and optimize their supply chain operations. These initiatives aim to enhance service efficiency, ensuring that patients receive necessary medical supplies promptly and healthcare providers can focus on delivering quality care.

Owens & Minor's unwavering commitment to innovation and quality has positioned it as a leader in healthcare logistics. For more detailed information, visit their official website.

Rhea-AI Summary

Owens & Minor, Inc. (NYSE: OMI) will be participating in the BofA Securities 2024 Health Care Conference on May 15, 2024. The company will have a webcasted fireside chat and one-on-one meetings with investors. Owens & Minor is a Fortune 500 global healthcare solutions company providing essential products and services. For more information, visit their website or follow them on social media.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
conferences
-
Rhea-AI Summary

Owens & Minor, Inc. (NYSE: OMI) reported financial results for Q1 2024 with consolidated revenue of $2.6 billion, a 4% YoY growth. GAAP EPS loss of $(0.29) and adjusted EPS of $0.19. Investments for long-term growth are on track. The company delivered top-line growth, improved profitability, and made strategic investments. The outlook for 2024 includes revenue of $10.5B to $10.9B, adjusted EBITDA of $550M to $590M, and adjusted EPS of $1.40 to $1.70.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-25.7%
Tags
-
Rhea-AI Summary
Owens & Minor, Inc. (NYSE: OMI) will release its financial results for the first quarter of 2024 on May 3, 2024, before trading begins on the NYSE. A conference call for investors and analysts will be held at 8:30 a.m. ET on the same day. Participants can access the call via toll-free or toll dial-in numbers. Interested stakeholders are encouraged to join the live webcast on the company's investor relations page.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.26%
Tags
Rhea-AI Summary
Owens & Minor, Inc. (OMI) reported strong financial results for the fourth quarter and full year 2023 with consolidated revenue of $10.3 billion, $741 million of operating cash flow, and significant debt reduction. The company showcased top-line growth, robust profit growth, and exceptional operating cash flow. The financial summary highlighted revenue, operating income, net income, and adjusted EBITDA for both periods. The fourth quarter results included consolidated revenue of $2.7 billion, operating income of $60 million, and adjusted operating income of $111 million. The company provided a financial outlook for 2024 with revenue expected to be in the range of $10.5 billion to $10.9 billion, adjusted EBITDA in the range of $550 million to $590 million, and adjusted EPS in the range of $1.40 to $1.70.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.56%
Tags
-
Rhea-AI Summary
Owens & Minor, Inc. (OMI) will release its Q4 2023 financial results on February 20, 2024, before trading begins on NYSE. An investor and analyst conference call will be held at 8:30 a.m. ET on the same day. Stakeholders can access the call via toll-free or toll dial-in numbers, along with a simultaneous live webcast. A replay of the webcast will be available on the investor relations page of the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.04%
Tags
-
Rhea-AI Summary
Owens & Minor, Inc. (NYSE: OMI) has unveiled its new purpose, Life Takes Care, reflecting the company's unique approach to caring for both the business and the humanity at the heart of healthcare. The President & Chief Executive Officer, Edward A. Pesicka, emphasizes the importance of defining this sense of purpose to better harness the collective strength, creativity, and compassion of the company's teammates as they continue to move the business forward.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.44%
Tags
none
Rhea-AI Summary
Owens & Minor, Inc. (NYSE: OMI) unveils a new five-year strategic plan targeting 20% compounded earnings growth between 2024 to 2028. The plan aims to unlock expanded profitability and growth profiles through investments, strong cash generation, and a value-enhancing capital allocation program.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.46%
Tags
none
-
Rhea-AI Summary
Owens & Minor, Inc. (NYSE: OMI) will host an Investor Day on December 6th at Convene in Boston, Massachusetts. The event will feature presentations from the senior executive leadership team, sharing the Company’s strategic vision, operating and growth strategy, and multi-year financial targets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.62%
Tags
conferences
-
Rhea-AI Summary
Owens & Minor, Inc. reported financial results for Q3 2023 with consolidated revenue of $2.59 billion and a net loss per common share of $(0.08). They achieved $188 million in total debt pay down and $117 million reduction in net debt. Patient Direct revenue increased by 9.1% compared to Q3 2022, while Products & Healthcare Services revenue increased by 2%. The company generated $157 million of operating cash flow in Q3 and provided a narrowed outlook for 2023 with revenue expected to be in the range of $10.3 billion to $10.4 billion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
27.08%
Tags
Rhea-AI Summary
Owens & Minor, Inc. to release Q3 2023 financial results on November 3, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.56%
Tags

FAQ

What is the current stock price of Owens & Minor (OMI)?

The current stock price of Owens & Minor (OMI) is $12.52 as of December 20, 2024.

What is the market cap of Owens & Minor (OMI)?

The market cap of Owens & Minor (OMI) is approximately 1.0B.

What does Owens & Minor, Inc. do?

Owens & Minor, Inc. is a healthcare logistics company that provides supply chain services for medical products, including disposable supplies, devices, and implants.

Where is Owens & Minor headquartered?

Owens & Minor is headquartered in Richmond, Virginia.

What are the main segments of Owens & Minor's business?

Owens & Minor operates under two main segments: Products & Healthcare Services and Patient Direct.

Who are Owens & Minor's customers?

Their customers include independent hospitals, large healthcare networks, group purchasing organizations, healthcare product manufacturers, and the federal government.

How much revenue does Owens & Minor generate annually?

Owens & Minor generates annualized revenues exceeding $9 billion.

What regions do Owens & Minor serve?

Owens & Minor serves markets in the United States and Europe.

What recent achievements has Owens & Minor accomplished?

Recent achievements include strategic partnerships and initiatives to optimize supply chain operations and enhance service efficiency.

What is the focus of the Products & Healthcare Services segment?

This segment focuses on manufacturing and sourcing medical-surgical products and providing solutions to prevent healthcare-associated infections.

What does the Patient Direct segment do?

The Patient Direct segment delivers disposable medical supplies directly to patients and home health agencies.

Where can I find more information about Owens & Minor?

More detailed information can be found on their official website.

Owens & Minor, Inc.

NYSE:OMI

OMI Rankings

OMI Stock Data

1.01B
75.01M
2.43%
103.02%
4.63%
Medical Distribution
Wholesale-medical, Dental & Hospital Equipment & Supplies
Link
United States of America
MECHANICSVILLE